Bank Of Nova Scotia Iovance Biotherapeutics, Inc. Transaction History

Bank Of Nova Scotia

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$5.62 - $10.0 $34,197 - $60,850	-6,085 Reduced 34.97%	11,315 $72,000
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $9.63 Million - $13.2 Million	-1,010,071 Reduced 98.31%	17,400 $167,000
Q2 2022 Aug 05, 2022	BUY	$6.38 - $18.33 $188,024 - $540,203	29,471 Added 2.95%	1,027,471 $11.3 Million
Q1 2022 May 09, 2022	BUY	$12.38 - $19.1 $12.4 Million - $19.1 Million	998,000 New	998,000 $16.6 Million

316

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $933M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.